The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 24, 2026

Filed:

Jun. 28, 2017
Applicants:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Cornell University, Ithaca, NY (US);

Inventors:

Michelle S. Bradbury, New York, NY (US);

Cameron Brennan, Haworth, NJ (US);

Mithat Gonen, New York, NY (US);

Mohan Pauliah, New York, NY (US);

Ulrich Wiesner, Ithaca, NY (US);

Assignees:

Memorial Sloan Kettering Cancer Center, New York, NY (US);

Cornell University, Ithaca, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61B 1/00 (2006.01); A61B 5/00 (2006.01); A61B 5/055 (2006.01); A61B 5/107 (2006.01); A61B 6/00 (2006.01); A61B 6/03 (2006.01); A61B 6/50 (2024.01); A61K 49/18 (2006.01); A61K 51/08 (2006.01); A61K 51/12 (2006.01); G01R 33/48 (2006.01); G01R 33/56 (2006.01); G01R 33/563 (2006.01); G01T 1/164 (2006.01); G01T 1/29 (2006.01); G06T 7/00 (2017.01); G06T 7/40 (2017.01); A61B 8/00 (2006.01); A61B 8/08 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0002 (2013.01); A61B 1/000094 (2022.02); A61B 5/0035 (2013.01); A61B 5/0042 (2013.01); A61B 5/055 (2013.01); A61B 5/1072 (2013.01); A61B 5/1075 (2013.01); A61B 5/4842 (2013.01); A61B 5/4848 (2013.01); A61B 6/03 (2013.01); A61B 6/037 (2013.01); A61B 6/481 (2013.01); A61B 6/501 (2013.01); A61B 6/5217 (2013.01); A61B 6/5247 (2013.01); A61K 49/1818 (2013.01); A61K 51/082 (2013.01); A61K 51/088 (2013.01); A61K 51/1244 (2013.01); G01R 33/481 (2013.01); G01R 33/4812 (2013.01); G01R 33/4814 (2013.01); G01R 33/5601 (2013.01); G01R 33/56341 (2013.01); G01T 1/1642 (2013.01); G01T 1/2985 (2013.01); G06T 7/0012 (2013.01); G06T 7/40 (2013.01); A61B 6/4417 (2013.01); A61B 8/085 (2013.01); A61B 8/4416 (2013.01); A61B 8/481 (2013.01); A61B 8/5223 (2013.01); A61B 8/5261 (2013.01); G06T 2207/10072 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/30096 (2013.01);
Abstract

Described herein are particle-driven radiogenomics systems and methods that can be used to identify imaging features for prediction of intratumoral and interstitial nanoparticle distributions in cancers (e.g., in low grade and/or high-grade brain cancers (e.g., gliomas, e.g., primary gliomas)). In certain embodiments, the systems and methods described herein extract and combine quantitative multi-dimensional data generated from structural, functional, and/or metabolic imaging. In certain embodiments, the combined multidimensional data is linked to intratumoral and interstitial nanoparticle distributions. For example, this linked data can be used to determine quantitative functional-metabolic multimodality particle-based imaging features and to predict treatment efficacy. These techniques provide an improved quantitative ability to measure treatment response and determine tumor progressions compared to traditional size-based imaging methods.


Find Patent Forward Citations

Loading…